MoBiDiK - Modular Bioproduction - Disposable and Continuous

Project objectives

The trend in pharmaceutical industry goes towards specialized therapies. This increases the need for more flexible and cost efficient production technologies and strategies.

Therefore it is the MoBiDiK project´s objective to achieve a paradigm change in the biopharmaceutical industry by using modular, disposable and continuous production technologies.

Conventional production process for monoclonal antibodies (source: Kauling, 2009)

INVITE's contribution

The INVITE Team contributes the development of production concepts and their physical demonstration in a pilot plant. By using innovative simulation and optimization methods, INVITE develops the optimal cascade and design of different unit operations to build an optimized production process. INVITE is the link between the different sub-projects from the up- and downstream parts and for this reason INVITE plays a key role within this project.

Project partner

  • Bayer Technology Services GmbH (Projektleitung)
  • Bayer Healthcare AG
  • FH Aachen
  • HiTec Zang
  • INVITE
  • PharmedArtis
  • RWTH Aachen
  • TU Dortmund
  • Uniklinikum Aachen

Funding

Contact

Dr. Martin Lobedann, Dipl.-Ing. Stephan Klutz

Project duration

3 years up to 31.07.2014

Trade fairs & Events

30th May - 1st June 2017 in Dubrovnik, Croatia

Virus & TSE Safety Forum more

25.01.2017 in Frankfurt, Germany

Open Workshop - Tackling the future of plant operation more

Press & News

05/03/2017 INVITE Kolloquium with Prof. Dr. Jörg Breitkreutz and Dr. Julian Quodbach more
07/26/2016 INVITE Colloquium with Prof. Dr. Dr. h.c. Peter Kleinebudde more

Map Directions

INVITE GmbH
Chempark Leverkusen
Building W32
51373 Leverkusen
Germany

Tel.: +49 214 31203-0
Email